Roche buys out Genentech with increased bid
March 12, 2009Sales and Marketing MA, Roche
Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …
Cervarix adverse reactions as expected, says MHRA
March 11, 2009Sales and Marketing GSK, vaccines
The government has played down reports about adverse reactions to GlaxoSmithKline's Cervarix, saying they are in line with expectations. The …
Recession helping smokers kick the habit
March 11, 2009Sales and Marketing healthcare
New research compiled to mark the UK's No Smoking Day suggests a third of the country's smokers are thinking about …
Foundation trusts’ private income limit could be dropped
March 11, 2009NHS
The House of Lords is set to debate an amendment to the Health Bill which could remove the private patient …
Obama ends stem cell funding ban
March 10, 2009Research and Development US, stem cell
President Obama has lifted the US ban on federal funding for new stem cell research, signalling another marked departure in …
Making a sales pitch in the ‘war for talent’
March 10, 2009Business Services UCB, recruitment
When I joined Celltech (now part of UCB) over 20 years ago it was difficult to attract candidates who valued …
Are biosimilars delivering the goods in the EU?
March 10, 2009Manufacturing and Production, Research and Development biosimilars
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …
Merck unveils $41 billion takeover of Schering-Plough
March 9, 2009Sales and Marketing MA, Merck
Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …
GSW unveils new European offering
March 6, 2009Medical Communications GSW
GSW Worldwide, one of the biggest global healthcare advertising agencies has announced the launch of a new pan-European offering.GSW is …
P&G sponsors ulcerative colitis DVD
March 6, 2009Sales and Marketing GI, digi
Procter & Gamble Pharmaceuticals is sponsoring and distributing a new educational DVD that aims to explain ulcerative colitis (UC) to …
UCB plans new Belgian biomanufacturing plant
March 6, 2009Manufacturing and Production UCB
Belgian biopharmaceutical company UCB has earmarked euros 65 million for the construction of its first biologics manufacturing plant in Braine-l'Alleud. …
UK’s Stem Cell Sciences acquired by US company
March 5, 2009Research and Development Stem cells
US company StemCells Inc is to expand its capabilities in the field with the purchase of UK based Stem Cell …
NICE rejects Tyverb despite price offer
March 5, 2009Research and Development NICE, Tyverb
NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …
Pfizer expands product deal with Indian generic company
March 5, 2009Sales and Marketing Asia, India, Pfizer, generics
Pfizer has linked up with Indian drug manufacturer Aurobindo Pharma to expand its portfolio of generic medicines in the US …
Obama makes ‘downpayment’ on US healthcare reform
March 5, 2009Research and Development US, healthcare
President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …
UK worst hit in Europe by pharma industry cutbacks
March 5, 2009Business Services, Sales and Marketing Jobs
The pharmaceutical industry's prolonged and painful period of restructuring looks set to continue, and UK pharma is thought to be …
Symbicort gains COPD indication
March 4, 2009Research and Development Symbicort
AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
